CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR

Clinical trial NCT02331693 · UNKNOWN

Trial details

NCT number: NCT02331693
Sponsor: RenJi Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Glioma

Start date: 2014-12-01
Primary completion: 2015-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.